New Tool in the Fight Against Osteoporosis Receives FDA Clearance

Share Article

Sunlight MiniOmni™ ultra-small bone sonometer for early assessment of Osteoporosis is also available in Europe and Canada

BeamMed, a leading provider of bone health-related measurement systems, today announced that its Sunlight MiniOmni™ bone sonometer has been cleared by the US Food and Drug Administration (FDA) and can now be marketed in the United States. Recently, the Sunlight MiniOmni also received a medical device license from Health Canada.

The Sunlight MiniOmni device received CE mark clearance in October 2010. To date, BeamMed has sold hundreds of Sunlight MiniOmni systems worldwide.

“Now that the North American market has been opened to us, we expect to see strong sales of the Sunlight MiniOmni, similar to the success we are achieving in Europe, Asia and the Far East” said Mr. Tal Marom, CEO, at BeamMed.

The Sunlight MiniOmni bone sonometer provides an exceptionally affordable, professional solution for early assessment of osteoporosis. It enables reliable, accurate, non-invasive and safe monitoring of bone density at the point of care. Its small size and weight, intuitive ease of use, and convenient USB-port connectivity to Windows-based PCs and laptops make it ideal for use in any physician office or medical clinic, pharmacy, annual checkup center or other retail venue.

Sunlight MiniOmni is based on the same proprietary quantitative ultrasound technology that has been proven in thousands of Sunlight Omnisense installations worldwide.

The Sunlight MiniOmni will be demonstrated at the upcoming Medica 2011 show in Dusseldorf, Germany, November 16-19, at the BeamMed booth, Hall 10, booth A34.

For more information, visit

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gilad Zamir
BeamMed Ltd.
+972-3-9236869 101
Email >

Maya Slai
BeamMed Ltd.
+972-3-9236869 110
Email >
Visit website